06 | Nirsevimab As a Key Strategy to Prevent Respiratory Syncytial Virus Among Newborns and Children: Real-World Evidence from Italy and Sicily. EuroMed Bio J 2026, 21 (s1). https://doi.org/10.3269/q1nt4g06.